Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.48 USD | +2.14% |
|
+5.57% | +15.97% |
Jul. 01 | Core Laboratories Inc.(NYSE:CLB) dropped from Russell 2000 Value Index | CI |
Jul. 01 | Core Laboratories Inc.(NYSE:CLB) dropped from Russell 2000 Value-Defensive Index | CI |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- Sales forecast by analysts have been recently revised upwards.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- With a 2024 P/E ratio at 25.15 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- The company is not the most generous with respect to shareholders' compensation.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Business Support Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+15.97% | 961M | B+ | ||
-.--% | 8.6B | - | - | |
-26.16% | 2.25B | - | ||
-31.06% | 2.26B | B+ | ||
-26.15% | 1.86B | - | - | |
-19.45% | 957M | - | ||
-17.84% | 938M | - | ||
-7.05% | 700M | - | - | |
-29.76% | 653M | - | ||
+0.19% | 546M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CLB Stock
- Ratings Core Laboratories Inc.